BIO-Europe EBD Group BIO BIO-Europe
Share:
Email this page Share this on LinkedIn Share this on Twitter

Additional Programs in Conjunction with BIO-Europe® 2014

Advanced Business Development Course 2014
October 31–November 2, 2014
Frankfurt, Germany

Take your skills to the next level by working directly with colleagues in a hands-on, practical course that uses a realistic business case!

The Advanced Business Development Course is designed for business development professionals interested in bringing their skills in valuation, due diligence, negotiation and contracts to the next level. During this intense, three-day session attendees will receive hands-on, advanced training from veteran business development professionals and legal advisers using real world case studies. In addition, attendees will be split into two teams to conduct a mock negotiation over a clinical stage compound.

This course has been organized for life science business development professionals by the Biotechnology Industry Organization in collaboration with EBD Group. The faculty is drawn from among the most experienced business development professionals in the biotech drug development industry as well as big pharma, many of whom have been instructors in other programs, and all of whom have extensive experience in the biotech industry.

The course will cover basic topics and skills crucial to every business development professional in the industry, including:

  • Valuation skills
  • Intellectual property
  • Due diligence
  • Negotiation and influence strategies

For more information go to: Advanced Business Development Course 2014

 


China Forum 2014
November 2, 2014
Frankfurt, Germany

China Forum 2014 will be a full day event, bringing together China-based life science executives with their counterparts from Europe and the rest of the world. The event will provide insights into recent developments of the rapidly changing life science industry in China.

Executives from China and the West will discuss partnering opportunities and attendees will gain essential knowledge on how to step into new marketplaces. In an interactive setting, attendees from Western countries will hear what it takes to succeed in China, and Chinese executives will learn how to leverage their business by partnering with European and American companies.

China Forum will precede EBD Group's international partnering conference, BIO-Europe 2014.

Who should attend?
  • Executives from China pharma and biotech companies.
  • CROs and CMOs seeking business opportunities in the West
  • Pharma and biotech executives from Europe and the US interested in doing business in China

For more information go to: China Forum 2014



EU-Japan Cluster Matchmaking Event
November 3, 2014
Frankfurt, Germany

The EU-Japan Cluster Matchmaking Event—financially supported by the European Commission (http://www.clustercollaboration.eu)—will take place during the first afternoon of BIO-Europe at the Portalhaus Messe Frankfurt on November 3. It provides the perfect opportunity to gain an overview of the strengths of the Japanese life sciences landscapes and clusters in the health care sector.

Speakers from four leading Japanese life science clusters and from Japan Bioindustry Association (JBA) will present the vast array of opportunities that the Japanese pharma and health market offers to European companies.

The event is free and does not require registration. For more information please visit http://bioxclusters.eu/.

The presentations and networking will take place in room Prisma from 15:15 to 18:00, followed by the BIO-Europe Exhibit Hall Hospitality Reception.

Agenda
15:15–15:30
Welcome address: European Commission-funded support tools
Jessica Michelson – EU-JAPAN CENTRE for Industrial Cooperation
15:30–15:45
The role of Personalized Health Care in Europe
Fabrizio Conicella – The European Strategic Cluster Partnership (ESCP) for Personalized Healthcare "bioXclusters"
15:45–16:15
Keynote: Opportunities for European biotech ventures in Japan
Dr. Tsuneaki Sakata – Vice president, All Japanese Bio Regions Committee
16:15–17:00
Japanese life science clusters
Metropolitan Bionetwork (Tokyo)
Yokohama-Kanagawa Bio-Business network (Kanagawa)
Protein Mall Kansai (Osaka)
Fukuoka BioCluster Project (Fukuoka)
17:00–18:00
Networking (business card exchange) around drinks and snacks
18:00
BIO-Europe Hospitality Reception in the Exhibit Hall

Chance for Business with Korea
Open Seminar by Korean Delegation Companies
November 5, 2014
Frankfurt, Germany

"Chance for Business with Korea" is a short event featuring Korean delegation companies presenting their advanced technology and opportunities for networking with Korean companies.

The event will provide insights into recent developments of the Korean Bio-medical industry.

The presentation and networking will take place in room Prisma on Level C at Portalhaus Messe Frankfurt during the third day of BIO-Europe from 09:30–12:00. It is open to all BIO-Europe participants interested in the Korean bio-medical market.

Agenda
9:30–10:00
Introduction of BIO KOREA 2015
KHIDI
10:00–10:20
Welcome address: New drug development and future business opportunity in Korea
KT&G Life Science
10:20–10:35
Introduction of antibody-drug conjugate technology
LegoChem Bioscience
10:35–10:50
DNA methylation biomarker-based noninvasive molecular tests for early colorectal detection
Genomictree
10:50–11:10
Neurological disease and neuropathic pain drug development
Medifron_DBT
11:10–11:25
Antibody Production technology using egg of a new concept
Adbiotech
11:30–12:00
Free networking

Pharmaceutical Licensing and Collaboration Agreements: Legal Considerations
November 6, 2014
Frankfurt, Germany

6+ hours of networking | 8 CPD points | 16+ speakers | 6 x in-house contributions

Informa Life Sciences' brand new ONE DAY conference takes an in-depth look at the full process from structuring a deal through to termination provisions. Providing an unrivalled opportunity for legal professionals to get a thorough grasp on how best to tackle the most prominent challenges in this field, Pharmaceutical Licensing and Collaboration Agreements 2014 is the best place to get a complete legal overview and hear from the best industry speakers.

Topics to be covered include structuring a deal and drafting a contract, negotiation strategies, due diligence, financial considerations, competition law, and termination provisions. With an Evening Seminar dedicated to alliance management in licensing deals and the drafting of termination provisions, Informa Life Sciences' new legal conference will ensure you are up to date with the most important legal decisions affecting industry over the past 12 months.

Our speaker panel includes representatives from:

Top Band Private Practice:
Taylor Wessing
Wragge Lawrence Graham & Co LLP
Covington & Burling LLP
Bristows
Fasken Martineau LLP
Reed Smith LLP
Expert In-House Counsel:
UCB
Vaccines GSK
STADA Group
Novo Nordisk
Les Laboratoires Servier
Takeda Pharmaceuticals

For more information please click here

Register Now


Arrow Up


© 2009–2014 EBD GmbH
BIO-Europe EBD Group BIO BIO-Europe